Videos de Experimentos Relacionados
Reducir la mortalidad por sarampión, reducir la mortalidad infantil.
Edward J Hoekstra1, Jeffrey W McFarland, Catherine Shaw
1Child Survival and Immunization Unit, Health Programme Division, UNICEF, New York City, NY 10017, USA. ehoekstra@unicef.org
Lancet (London, England)
|September 26, 2006
Resumen
No abstract available in PubMed .
Videos de Conceptos Relacionados
También podría leer
Artículos Relacionados
Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.
Ordenar por
Same author
Vaccination strategies for Ebola in the democratic republic of Congo: the WHO-Ebola modeling collaboration.
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2025
Same author
Ebola Outbreak Response in the DRC with rVSV-ZEBOV-GP Ring Vaccination.
The New England journal of medicine·2024
Same author
Educational impact and recommendations from implementation of student-led clinical trial recruitment: a mixed-methods study.
Postgraduate medical journal·2023
Same author
Transplantation of PSC-derived myogenic progenitors counteracts disease phenotypes in FSHD mice.
NPJ Regenerative medicine·2022
Same author
The impact of preoperative oral nutrition supplementation on outcomes in patients undergoing gastrointestinal surgery for cancer in low- and middle-income countries: a systematic review and meta-analysis.
Scientific reports·2022
Same author
Burden of Influenza-Associated Respiratory Hospitalizations, Vietnam, 2014-2016.
Emerging infectious diseases·2021
Same journal
Assisted dying and the silencing of medicine's next generation.
Lancet (London, England)·2026
Same journal
Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.
Lancet (London, England)·2026
Same journal
Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.
Lancet (London, England)·2026
Same journal
[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.
Lancet (London, England)·2026
Same journal
Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.
Lancet (London, England)·2026